Not Yet Recruiting
Neoadjuvant With Tα1 Plus Immuno-chemotherapy for Resectable NSCLC
NCT06607926
- Conditions
- Bronchial Neoplasms, Carcinoma, Bronchogenic, Carcinoma, Non-Small-Cell Lung, +8 more
- Locations
-
- Xuanwu Hospital, Capital Medical University Beijing, China